Trade Summary

4 days ago, Riley Antony A, serving as CFO at Forte Biosciences, Inc. (FBRX), purchased 9,680 shares at $26.33 per share, for a total transaction value of $254,833.00. Following this transaction, Riley Antony A now holds 41,741 shares of FBRX.

This purchase represents a 30.00% increase in Riley Antony A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, December 30, 2025 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, 3 days after the trade was made.

Forte Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.